Accuray Incorporated (ARAY) vs Elicio Therapeutics, Inc. (ELTX)

A side-by-side comparison of Accuray Incorporated and Elicio Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Accuray Incorporated logo
ARAY
Accuray Incorporated
$37M
$0.31HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Elicio Therapeutics, Inc. logo
ELTX
Elicio Therapeutics, Inc.
$36M
$1.91HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT

Total return — ARAY vs ELTX

growth of $100 · dividends reinvested · last 3y
ARAY -88.2% (-50.9%/yr)ELTX -67.4% (-31.2%/yr)ELTX compounded faster over this window
050100150200250Start $100202420252026$12$33
ARAY ELTX

ARAY vs ELTX: by the numbers

  • •ARAY is the larger company ($37M vs $36M market cap).
  • •Both run net losses; ELTX's is the smaller (0.00% vs -12.24% net margin).

Metrics side by side

Valuation

MetricARAYELTX
P/S ratio0.09N/A
P/B ratio0.884.58

Profitability

MetricARAYELTX
Gross margin27.73%0.00%
Operating margin-6.58%0.00%
Net margin-12.24%0.00%
ROE-117.97%-476.77%
ROIC-10.09%-171.36%

Growth (annualized)

MetricARAYELTX
Revenue CAGR (5Y)0.28%N/A
Total return CAGR (5Y)-39.94%N/A

Go deeper

Full ARAY analysisFull ELTX analysisInteractive comparison tool

Dig into the metrics

Accuray ROEElicio Therapeutics ROEAccuray operating marginElicio Therapeutics operating marginAccuray revenue growthElicio Therapeutics revenue growthAccuray free cash flowElicio Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.